Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin‐induced thrombocytopenia‐reactive antibodies or with true HIT (HIT‐reactive antibodies plus thrombocytopenia): An 11‐year experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|7|608-617

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.7, 2015-07, pp. : 608-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pseudo-Pulmonary Embolism as a Sign of Acute Heparin-Induced Thrombocytopenia in Hemodialysis Patients: Safety of Resuming Heparin after Disappearance of HIT Antibodies

By  

Nephron Clin Pract, Vol. 104, Iss. 4, 2006-08 ,pp. : c143-c148

Karger

Access to resources Recommend Favorite

Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases

By Tardy-Poncet B.   Wolf M.   Lasne D.   Bauters A.   Ffrench P.   Elalamy I.   Tardy B.  

Intensive Care Medicine, Vol. 35, Iss. 8, 2009-08 ,pp. : 1449-1453

Springer Publishing Company

Access to resources Recommend Favorite

Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 308-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Surface PF4: Glycosaminoglycan Complexes in the Pathogenesis of Heparin-Induced Thrombocytopenia (HIT)

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 46-49

Karger

Access to resources Recommend Favorite

Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1900-1907

John Wiley & Sons Inc

Access to resources Recommend Favorite